Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease

NCT02719496 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Disorders in Parkinson's Disease

Interventions

DRUG: IBEROGAST

Sponsor

Nantes University Hospital